Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
RVX.TOthis companyResverlogix Corp.	CA$0.08	-2.63×	-0.23×	0×	-19.6×	-567.0%	0.0%	0.0%	0.0%	8.9%	33.9%	-18.0%	-0.82×	-15.24×	-1.2×	0.04×	0.0%	2	-90.42	1	C-
AVCN.TOAvicanna Inc.	CA$0.11	-9.07×	9.08×	1.01×	-12.94×	-14577.3%	50.4%	-10.7%	-11.2%	-100.0%	-22.5%	-5.6%	0×	0.14×	-52.39×	0.86×	0.0%	3	-4.88	2	C
BCT.TOBriaCell Therapeutics Corp.	CA$5.51	-0.68×	1.47×	0×	-0.39×	-83.3%	0.0%	0.0%	0.0%	-216.0%	-234.6%	-120.9%	0×	0.27×	0×	2.76×	0.0%	1	-10.15	2	C
DOSE.CNRapid Dose Therapeutics Corp.	CA$0.11	-5.88×	-2.78×	7.19×	-15.23×	-398.4%	-34.5%	-78.3%	-122.2%	47.2%	117.1%	-1.4%	-0.74×	-3.2×	-1.78×	0.04×	0.0%	3	-27.84	2	C
HEM.VHemostemix Inc.	CA$0.05	-3.13×	-2.96×	0×	-4.14×	-154.2%	0.0%	0.0%	0.0%	94.8%	637.9%	-30.8%	-0.72×	-0.69×	-10.05×	0.49×	0.0%	1	-454.38	2	C
LABS.TOMediPharm Labs Corp.	CA$0.07	-3.32×	0.76×	0.61×	-2.56×	-3416.7%	31.0%	-18.6%	-18.3%	-23.1%	-23.3%	-20.5%	0.01×	1.62×	-133.46×	2.77×	0.0%	3	-2.72	2	C+
Peer median	—	-3.32×	0.76×	0.61×	-4.14×	-398.4%	0.0%	-10.7%	-11.2%	-23.1%	-22.5%	-20.5%	0×	0.14×	-10.05×	0.86×	0.0%	3	-10.15	2	—